Literature DB >> 34416276

Diversity and Inclusion in Pancreatic Cancer Clinical Trials.

Kelly M Herremans1, Andrea N Riner1, Robert A Winn2, Jose G Trevino3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34416276      PMCID： PMC8840813          DOI： 10.1053/j.gastro.2021.06.079

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  20 in total

1.  Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial.

Authors:  Talia Golan; Hedy L Kindler; Joon Oh Park; Michele Reni; Teresa Macarulla; Pascal Hammel; Eric Van Cutsem; Dirk Arnold; Daniel Hochhauser; David McGuinness; Gershon Y Locker; Teodora Goranova; Philipp Schatz; Yu-Zhen Liu; Michael J Hall
Journal:  J Clin Oncol       Date:  2020-02-19       Impact factor: 44.544

2.  Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions.

Authors:  Emily M Rencsok; Latifa A Bazzi; Rana R McKay; Franklin W Huang; Adam Friedant; Jake Vinson; Samuel Peisch; Jelani C Zarif; Stacey Simmons; Kelly Hawthorne; Paul Villanti; Philip W Kantoff; Elisabeth Heath; Daniel J George; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06-05       Impact factor: 4.254

Review 3.  Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.

Authors:  Luther T Clark; Laurence Watkins; Ileana L Piña; Mary Elmer; Ola Akinboboye; Millicent Gorham; Brenda Jamerson; Cassandra McCullough; Christine Pierre; Adam B Polis; Gary Puckrein; Jeanne M Regnante
Journal:  Curr Probl Cardiol       Date:  2018-11-09       Impact factor: 5.200

4.  The effect of patient race and socio-economic status on physicians' perceptions of patients.

Authors:  M van Ryn; J Burke
Journal:  Soc Sci Med       Date:  2000-03       Impact factor: 4.634

5.  Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.

Authors:  Kenneth L Kehl; Neeraj K Arora; Deborah Schrag; John Z Ayanian; Steven B Clauser; Carrie N Klabunde; Katherine L Kahn; Robert H Fletcher; Nancy L Keating
Journal:  J Natl Cancer Inst       Date:  2014-09-13       Impact factor: 13.506

6.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

7.  Enrollment of African Americans onto clinical treatment trials: study design barriers.

Authors:  Lucile L Adams-Campbell; Chiledum Ahaghotu; Melvin Gaskins; Fitzroy W Dawkins; Duane Smoot; Octavius D Polk; Robert Gooding; Robert L DeWitty
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

Review 8.  Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.

Authors:  Moon S Chen; Primo N Lara; Julie H T Dang; Debora A Paterniti; Karen Kelly
Journal:  Cancer       Date:  2014-04-01       Impact factor: 6.860

Review 9.  Are racial and ethnic minorities less willing to participate in health research?

Authors:  David Wendler; Raynard Kington; Jennifer Madans; Gretchen Van Wye; Heidi Christ-Schmidt; Laura A Pratt; Otis W Brawley; Cary P Gross; Ezekiel Emanuel
Journal:  PLoS Med       Date:  2005-12-06       Impact factor: 11.069

10.  Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.

Authors:  Andrea N Riner; Patrick W Underwood; Kai Yang; Kelly M Herremans; Miles E Cameron; Srikar Chamala; Peihua Qiu; Thomas J George; Jennifer B Permuth; Nipun B Merchant; Jose G Trevino
Journal:  Cancer Med       Date:  2020-04-13       Impact factor: 4.452
View more
  4 in total

1.  A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities.

Authors:  Jennifer B Permuth; Benjamin D Powers; Pamela J Hodul
Journal:  Gastroenterology       Date:  2022-05-02       Impact factor: 33.883

Review 2.  Inclusion and diversity in clinical trials: Actionable steps to drive lasting change.

Authors:  Michelle D Kelsey; Bray Patrick-Lake; Raolat Abdulai; Uli C Broedl; Adam Brown; Elizabeth Cohn; Lesley H Curtis; Chris Komelasky; Michael Mbagwu; George A Mensah; Robert J Mentz; Amesika Nyaku; Stephanie O Omokaro; Judy Sewards; Kendal Whitlock; Xinzhi Zhang; Gerald S Bloomfield
Journal:  Contemp Clin Trials       Date:  2022-03-29       Impact factor: 2.261

3.  Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.

Authors:  Andrea N Riner; Selamawit Girma; Vignesh Vudatha; Nitai Mukhopadhyay; Nevena Skoro; Tamas S Gal; Devon C Freudenberger; Kelly M Herremans; Thomas J George; Jose G Trevino
Journal:  J Clin Oncol       Date:  2022-03-22       Impact factor: 50.717

4.  ASO Author Reflections: Seizing the Momentum to Diversify Cancer Clinical Trial Enrollment.

Authors:  Mariam F Eskander; Samilia Obeng-Gyasi; Allan Tsung
Journal:  Ann Surg Oncol       Date:  2021-10-16       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.